Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-25-002214
Filing Date
2025-01-14
Accepted
2025-01-14 17:09:43
Documents
85

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 3180766
2 ex23-2.htm EX-23.2 3649
3 CALCULATION OF FILING FEE TABLES ex107.htm EX-FILING FEES 19233
  Complete submission text file 0001493152-25-002214.txt   12095624

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE envb-20240930.xsd EX-101.SCH 81655
5 XBRL CALCULATION FILE envb-20240930_cal.xml EX-101.CAL 82045
6 XBRL DEFINITION FILE envb-20240930_def.xml EX-101.DEF 335751
7 XBRL LABEL FILE envb-20240930_lab.xml EX-101.LAB 631134
8 XBRL PRESENTATION FILE envb-20240930_pre.xml EX-101.PRE 486808
87 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 2039792
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-284277 | Film No.: 25530156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)